Cubist Systematic Strategies’s Urovant Sciences Ltd. UROV Stock Holding History

Cubist Systematic Strategies’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,800	Closed	-$287K	–	3046
2020 Q4	$287K	Buy	+17,800	New	+$221K	﹤0.01%	2062
2019 Q4	–	Sell	-1,239	Closed	-$12K	–	2621
2019 Q3	$12K	Buy	+1,239	New	+$10.7K	﹤0.01%	2141
2019 Q1	–	Sell	-447	Closed	-$3K	–	2493
2018 Q4	$3K	Buy	+447	New	+$4.07K	﹤0.01%	2010

Cubist Systematic Strategies's UROV Position: Q1 2021 in Review

Cubist Systematic Strategies sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 17,800 shares — an estimated $287K sold.

Cubist Systematic Strategies first reported a position in UROV in Q4 2018 and held it in 3 quarters. The position peaked at $287K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Cubist Systematic Strategies reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 17,800 Urovant Sciences Ltd. shares in Q1 2021, an estimated $287K.
Cubist Systematic Strategies first reported a position in Urovant Sciences Ltd. in Q4 2018 and held it in 3 quarters.
Cubist Systematic Strategies's Urovant Sciences Ltd. position peaked at $287K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.